메뉴 건너뛰기




Volumn 8, Issue 11, 1998, Pages 1359-1364

The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement

Author keywords

[No Author keywords available]

Indexed keywords

MARIMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

EID: 18344415400     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00218-2     Document Type: Article
Times cited : (20)

References (17)
  • 9
    • 0026505650 scopus 로고
    • 6. The following literature procedure was adapted to determine the potency of compounds against recombinant MMP enzymes. Knight, C. G.; Willenbrock, F.; Murphy, G.; FEBS Letters 296,1992, 3, 263-266.
    • (1992) FEBS Letters 296 , vol.3 , pp. 263-266
    • Knight, C.G.1    Willenbrock, F.2    Murphy, G.3
  • 14
    • 0010434404 scopus 로고    scopus 로고
    • unpublished results
    • 9. Groups of male rats (n=12) were dosed orally with the test compounds (10 mg/Kg), serial blood samples were removed and MMPI activity extracted and assayed against HFC. Concentrations were calculated against a standard curve; Bone, E. A.; Askew, M.; Laber, D.; unpublished results.
    • Bone, E.A.1    Askew, M.2    Laber, D.3
  • 15
    • 0010473887 scopus 로고    scopus 로고
    • note
    • 10. C Log P calculations were carried out using a CLOGP program by Daylight Software.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.